Zak Mir interviews Joao Andrade, CEO of Widecells. Click the play button to listen to the audio.
Key points discussed:
- Why are stem cells significant and how is Widecells taking advantage?
- How competitive is the market for stem cell heath care insurance?
- In which countries do you see the best growth opportunities?
- Do you intend to launch any additional products?
- Are the funds you recently raised enough to get through to profitability?
For more research on Widecells visit http://www.alignresearch.co.uk/cpt-company/widecells-group/
Widecells is a research client of Align Research. Align Research owns shares in WideCells. This investment may not be suitable for your personal circumstances. If you are in any doubt as to its suitability you should seek professional advice. This does not constitute advice and your capital is at risk. This is a marketing communication and cannot be considered independent research.